Factor XI Inhibitors Are a Safer Option for Stroke Prevention | ACC 2025
Source: Managed Healthcare Executive
Factor XI Inhibitors are the alternative to DOACs, which are highly effective at preventing strokes. However, their bleeding risks often limit their use, especially in high-risk patients.
Factor XI inhibitors are on the rise as a potential breakthrough therapy in treating anticoagulation, as they offer a safer alternative to direct oral anticoagulants (DOACs) for atrial fibrillation patients, according to Christian T. Ruff, M.D., M.P…. [1236 chars]